Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 53.5% in January

Biomerica, Inc. (NASDAQ:BMRA) saw a significant decrease in short interest in January. As of January 15th, there was short interest totalling 364,100 shares, a decrease of 53.5% from the December 31st total of 782,800 shares. Based on an average daily volume of 894,000 shares, the short-interest ratio is presently 0.4 days.

Biomerica Price Performance

NASDAQ:BMRA traded down $0.03 during trading hours on Wednesday, reaching $0.66. 367,183 shares of the company traded hands, compared to its average volume of 23,560,881. The firm’s 50-day moving average is $0.37 and its 200-day moving average is $0.35. The stock has a market cap of $12.03 million, a P/E ratio of -1.93 and a beta of -1.04. Biomerica has a 1-year low of $0.24 and a 1-year high of $1.35.

Biomerica (NASDAQ:BMRA) last posted its quarterly earnings data on Tuesday, January 14th. The company reported ($0.06) EPS for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.